These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38066364)

  • 1. Bacteriophage Production in Compliance with Regulatory Requirements.
    Pirnay JP; Merabishvili M; De Vos D; Verbeken G
    Methods Mol Biol; 2024; 2734():89-115. PubMed ID: 38066364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage Production in Compliance with Regulatory Requirements.
    Pirnay JP; Merabishvili M; Van Raemdonck H; De Vos D; Verbeken G
    Methods Mol Biol; 2018; 1693():233-252. PubMed ID: 29119444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine.
    Verbeken G; Pirnay JP; De Vos D; Jennes S; Zizi M; Lavigne R; Casteels M; Huys I
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):161-72. PubMed ID: 22527355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Call for a dedicated European legal framework for bacteriophage therapy.
    Verbeken G; Pirnay JP; Lavigne R; Jennes S; De Vos D; Casteels M; Huys I
    Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):117-29. PubMed ID: 24500660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for Bacteriophage Product Certification.
    Fauconnier A
    Methods Mol Biol; 2018; 1693():253-268. PubMed ID: 29119445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.
    Verbeken G; Huys I; De Vos D; De Coninck A; Roseeuw D; Kets E; Vanderkelen A; Draye JP; Rose T; Jennes S; Ceulemans C; Pirnay JP
    FEMS Microbiol Lett; 2016 Feb; 363(4):. PubMed ID: 26678555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview.
    Kwiatek M; Parasion S; Nakonieczna A
    J Appl Microbiol; 2020 Apr; 128(4):985-1002. PubMed ID: 31778593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary biology and development model of medicines: A necessary 'pas de deux' for future successful bacteriophage therapy.
    Froissart R; Brives C
    J Evol Biol; 2021 Dec; 34(12):1855-1866. PubMed ID: 34288190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magistral Phage Preparations: Is This the Model for Everyone?
    Pirnay JP; Verbeken G
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S360-S369. PubMed ID: 37932120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antibiotic Efflux Protein TolC Is a Highly Evolvable Target under Colicin E1 or TLS Phage Selection.
    Tamer YT; Gaszek I; Rodrigues M; Coskun FS; Farid M; Koh AY; Russ W; Toprak E
    Mol Biol Evol; 2021 Sep; 38(10):4493-4504. PubMed ID: 34175926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress toward the implementation of phage therapy in Western medicine.
    Pirnay JP; Ferry T; Resch G
    FEMS Microbiol Rev; 2022 Jan; 46(1):. PubMed ID: 34289033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage therapy--cooked goose or phoenix rising?
    Mattey M; Spencer J
    Curr Opin Biotechnol; 2008 Dec; 19(6):608-12. PubMed ID: 18926909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of regulated clinical trials in the development of bacteriophage therapeutics.
    Parracho HM; Burrowes BH; Enright MC; McConville ML; Harper DR
    J Mol Genet Med; 2012; 6():279-86. PubMed ID: 22872803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking bacteriophage therapy seriously: a moral argument.
    Verbeken G; Huys I; Pirnay JP; Jennes S; Chanishvili N; Scheres J; Górski A; De Vos D; Ceulemans C
    Biomed Res Int; 2014; 2014():621316. PubMed ID: 24868534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European regulatory aspects of phage therapy: magistral phage preparations.
    Verbeken G; Pirnay JP
    Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.